Lectures ( Tenative Prograam)

Rafaela Salgado Ferreira

UFMG

Desenvolvimento racional de inibidores de proteases para tratamento de doenças negligenciadas e emergentes

Hugo Verli

UFRGS

The role of molecular dynamics on drug discovery

Ernesto Cafarena

FIOCRUZ/RJ

Lessons from computational experiments by combining CpHMD and Free energy calculations

Mauricio Garcia de Souza Costa

Fiocruz/RJ

MDeNM-EMfit: Ajuste Flexível de Estruturas em Mapas de Crio-Microscopia Eletrônica utilizando a Dinâmica Molecular com Modos Normais Excitados

Pedro Geraldo Pascutti

UFRJ

Molecular Dynamics and Normal Mode Analysis in Allosteric Inhibitor Design

Gustavo Henrique Goulart Trossini

USP

Sirtuin 2 an epigenetic target to design new antichagasic candidates

Priscila Capriles Goliatt

USP

Computational Modeling in Health - from Nano to Giga

Abstract (click here)

According to the World Health Organization, health is "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity." But how to assess the completeness in each of these states and also the relationship between them given the complexity of observing and experimentally measuring all the phenomena involved? Computational Modeling comes as an alternative to this issue, given its ability to simulate different solutions for phenomena of the most different scales and complexities. In this meeting, we will talk about how the GMCA (Group of Applied Computational Modeling) has been developing research and applications in Computational Modeling for the health area, involving problems from the nanometric scale to population scales.

Lecture 8